CAY10505
CAS No. 1218777-13-9
CAY10505( CAY10505 | CAY 10505 | CAY10505 )
Catalog No. M10821 CAS No. 1218777-13-9
CAY10505 is dehydroxyl of AS-252424, which is a PI3Kγ inhibitor with IC50 of 33 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 168 | In Stock |
|
| 200MG | 250 | In Stock |
|
| 500MG | 428 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10505
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10505 is dehydroxyl of AS-252424, which is a PI3Kγ inhibitor with IC50 of 33 nM.
-
DescriptionCAY10505 is dehydroxyl of AS-252424, which is a PI3Kγ inhibitor with IC50 of 33 nM.
-
In VitroA class IB PI3Kγ isoform inhibitor CAY10505 at 200 nM (IC50=30 nM) partially reduces the baicalein-induced Akt phosphorylation in neurons. The pharmacological PI3K inhibitor CAY10505 (PIK3CG) is tested on an extended panel of multiple myeloma (MM) cell lines and freshly isolated primary MM samples. MM cells are CAY10505-treated for 3 d (MM cell lines) or 5 d (primary MM cells) respectively, and survival is analysed by flow cytometry (annexin V-FITC/PI staining). Treatment of bone marrow stromal cells (BMSCs)-co-cultured primary MM samples with the PIK3CA inhibitor CAY10505 results in anti-survival effects (mean survival relative to DMSO-treated controls: CAY10505: 84±14%, tested at 10 μM).
-
In VivoAdministration of CAY10505 (0.6 mg/kg, p.o.), Losartan (25 mg/kg, p.o.), or Atorvastatin (30 mg/kg, p.o.) significantly increases serum nitrite and (or) nitrate concentrations in hypertensive rats. Acetylcholine (ACh) and Sodium nitroprusside (SNP) produce endothelium-dependent and-independent relaxation in isolated rat aortic ring precontracted with Phenylephrine (3 μM), in a dose dependent manner. Administration of CAY10505 (0.6 mg/kg,p.o.), Losartan (25 mg/kg, p.o.), or Atorvastatin (30 mg/kg, p.o.) significantly prevents hypertension-induced attenuation of ACh-induced endothelium-dependent relaxation. Deoxycorticosterone acetate salt (DOCA, 40 mg/kg, s.c.) induced hypertension markedly attenuates acetylcholine-induced endothelium-dependent relaxation, but does not affect SNP-induced endotheliumindependent relaxation.
-
SynonymsCAY10505 | CAY 10505 | CAY10505
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kγ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1218777-13-9
-
Formula Weight289.28
-
Molecular FormulaC14H8FNO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 58 mg/mL (200.49 mM)
-
SMILESO=C(NC/1=O)SC1=C\C2=CC=C(C3=CC=C(F)C=C3)O2
-
Chemical Name(E)-5-((5-(4-fluorophenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tyagi S, Sharma S, Budhiraja RD.Can J Physiol Pharmacol. 2012 Jul;90(7):881-5.
molnova catalog
related products
-
LTURM34
LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines.
-
BAY 1082439
BAY 1082439 is a potent, highly selective, orally available PI3Kα/β inhibitor, selectively inhibits both PI3Kα.
-
Trihexyphenidyl hydr...
Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class.
Cart
sales@molnova.com